ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

216
Analysis
Health Care • South Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
Exchange Announcement • 09 Jan 2024 17:56

Delisting(피흡수합병)

Exchange Announcement • 13 Dec 2023 17:08

Suspension of Trading(주식의 병합, ë¶„í• ë“± ì „ìžë“±ë¡ 변경, 말소)

Exchange Announcement • 07 Nov 2023 09:10

Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)

Exchange Announcement • 02 Nov 2023 10:27

Prior Notice on Disclosure of Final Earnings

Exchange Announcement • 23 Oct 2023 12:59

Outcomes of Extraordinary General Meeting of Shareholders

x